- Perazell M. A. (2009). Renal vulnerability to drug toxicity. Clinical Journal of the American Society of Nephrology, 4(7), 1275-1283.
- Miller R. P., Tadagavadi, R. K., Ramesh, G., & Reeves, W. B. (2010). Mechanisms of cisplatin nephrotoxicity. Toxins, 2(11), 2490-2518.
- Zhu X., Jiang X., Li A., Zhao Z., & Li S. (2017). S‐Allylmercaptocysteine attenuates cisplatin‐induced nephrotoxicity through suppression of apoptosis, oxidative stress, and inflammation. Nutrients, 9(), 166.
- Kumar P., Sulakhiya K., Barua C. C., & Mundhe N. (2017). TNF-α, IL-6 and IL-10 expressions, responsible for disparity in action of curcumin against cisplatin-induced nephrotoxicity in rats. Molecular and Cellular Biochemistry, 431(1), 113-122.
- Chtourou Y., Aouey B., Kebieche M., & Fetoui H. (2015). Protective role of naringin against cisplatin induced oxidative stress, inflammatory response and apoptosis in rat striatum via suppressing ROS-mediated NF-κB and P53 signaling pathways. Chemico-Biological Interactions, 239, 76-86.
- Saral S., Ozcelik E., Cetin A., Saral O., Basak N., Aydın M., & Ciftci O. (2016). Protective role of diospyros lotus on cisplatin‐induced changes in sperm characteristics, testicular damage and oxidative stress in rats. Andrologia, 48(3), 308-317.
- Pedraza-Chaverrí J., Barrera D., Maldonado P. D., Chirino Y. I., Macías-Ruvalcaba N. A., Medina-Campos O. N., & Hernández-Pando R. (2004). S-allylmercaptocysteine scavenges hydroxyl radical and singlet oxygen in vitro and attenuates gentamicin-induced oxidative and nitrosative stress and renal damage in vivo. BMC Clinical Pharmacology, 4(1), 5.
- Divya M. K., Lincy L., Raghavamenon A. C., & Babu T. D. (2016). Ameliorative effect of Apodytes dimidiata on cisplatin-induced nephrotoxicity in Wistar rats. Pharmaceutical Biology, 54(10), 2149-2157.
- Romero F., Pérez M., Chávez M., Parra G., & Durante P. (2009). Effect of uric acid on gentamicin‐induced nephrotoxicity in rats–role of matrix metalloproteinases 2 and 9. Basic & Clinical Pharmacology & Toxicology, 105(6), 416-424.
- Ali B. H., & Al Moundhri M. S. (2006). Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food and Chemical Toxicology, 44(8), 1173-1183.
- Kagal UA, Angadi NB, Matule SM. (2017). Effect of dipeptidyl peptidase 4 inhibitors on acute and subacute models of inflammation in male Wistar rats: an experimental study. International Journal of Applied and Basic Medical Research, 7(1), 26.
- Cornell S. (2014). Type 2 diabetes treatment recommendations update: Appropriate use of dipeptidyl peptidase-4 inhibitors. J Diabetes Metabolism, 5(414), 2.
- Uchii M., Sakai M., Hotta Y., Saeki S., Kimoto N., Hamaguchi A., & Kunori S. (2017). The persistent inhibitory properties of saxagliptin on renal dipeptidyl peptidase-4: Studies with HK-2 cells in vitro and normal rats in vivo. Journal of Pharmacological Sciences, 135(3), 126-130.
- Sakai M., Uchii M., Myojo K., Kitayama T., & Kunori S. (2015). Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats. European Journal of Pharmacology, 761, 109-115.
- Naghizadeh B., Boroushaki M. T. Vahdati M., N., & Mansouri M. T. (2008). Protective effects of crocin against cisplatin-induced acute renal failure and oxidative stress in rats. Iranin Biomedical Journal ,12(1),93-100.
- Van Herck H., Baumans V., Brandt C. J. W. M., Hesp A. P. M., Sturkenboom J. H., Van Lith H. A., & Beynen A. C. (1998). Orbital sinus blood sampling in rats as performed by different animal technicians: the influence of technique and expertise. Laboratory Animals, 32(4), 377-386.
- Vane J. R., & Botting R. M. (1998). Anti-inflammatory drugs and their mechanism of action. Inflammation Research, 47(2), 78-87.
- Miller R. P., R. K. Tadagavadi G. Ramesh and W. B. Reeves (2010). "Mechanisms of Cisplatin nephrotoxicity." Toxins (Basel) 2(11): 2490-2518.
- Alhoshani A. R., Hafez M. M., Husain S., Al-Sheikh A. M., Alotaibi M. R., Al Rejaie S. S., ... & Al-Shabanah O. A. (2017). Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats. BMC nephrology, 18(1), 1-10.
- Duffy, E. A., Fitzgerald W., Boyle K., & Rohatgi R. (2018). Nephrotoxicity: Evidence in patients receiving cisplatin therapy. Clinical Journal of Oncology Nursing, 22(2).
- Fadini G. P. & A. Avogaro (2011). "Cardiovascular effects of DPP-4 inhibition: beyond GLP-1." Vascular Pharmacology 55(1-3): 10-16.
- Wang R., Hassan W., Jabeen, Q., Ahmed H., & Iqbal O. (2019). Citrus aurantium ameliorates cisplatin-induced nephrotoxicity. BioMed Research International, 2019.
- Alhadeff A. L., Holland R. A., Zheng H., Rinaman L., Grill H. J., & De Jonghe B. C. (2017). Excitatory hindbrain–forebrain communication is required for cisplatin-induced anorexia and weight loss. Journal of Neuroscience, 37(2), 362-370.
- Abdel-Aal R. A., Abdel-Rahman M. S., Al Bayoumi S., & Ali L. A. (2020). Effect of stevia aqueous extract on the antidiabetic activity of saxagliptin in diabetic rats. Journal of Ethnopharmacology, 265, 113188.
- Poucher S. M., Cheetham S., Francis J., Zinker B., Kirby M., & Vickers S. P. (2012). Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β‐cell mass in a streptozotocin‐induced mouse model of type 2 diabetes. Diabetes, Obesity and Metabolism, 14(10), 918-926.
- Xu, Yanfang, Huabin Ma, Jing Shao, Jianfeng Wu, Linying Zhou, Zhirong Zhang, Yuze Wang et al. "A role for tubular necroptosis in cisplatin-induced AKI." (2015) Journal of the American Society of Nephrology, 26 (11), 2647-2658.
- Saad S. Y., Najjar T. A., Daba M. H., & Al-Rikabi A. C. (2002). Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine. Chemotherapy, 48(6), 309-315.
- Haghighi M., Nematbakhsh M., Talebi A., Nasri H., Ashrafi F., Roshanaei K., ... & Safari T. (2012). The role of angiotensin II receptor 1 (AT1) blockade in cisplatin-induced nephrotoxicity in rats: gender-related differences. Renal failure, 34(8), 1046-1051.
- Helal M. G., M. Zaki and E. Said (2018). "Nephroprotective effect of saxagliptin against gentamicin-induced nephrotoxicity, emphasis on anti-oxidant anti-inflammatory and anti-apoptic effects." Life Science 208: 64-71.
- Abdel Moneim A. E., Othman M. S., & Aref A. M. (2014). Azadirachta indica attenuates cisplatin-induced nephrotoxicity and oxidative stress. BioMed ResearchInternational, 2014.
- Ali B. H., Al Moundhri M. S., Tag Eldin M., Nemmar A., & Tanira M. O. (2007). The ameliorative effect of cysteine prodrug L‐2‐oxothiazolidine‐4‐carboxylic acid on cisplatin‐induced nephrotoxicity in rats. Fundamental & Clinical Pharmacology, 21(5), 547-553.
- Alibakhshi T., Khodayar M. J., Khorsandi L., Rashno M., & Zeidooni L. (2018). Protective effects of zingerone on oxidative stress and inflammation in cisplatin-induced rat nephrotoxicity. Biomedicine & Pharmacotherapy, 105, 225-232.
- Abdelrahman A. M., Y. A. Suleimani M. A. Za'abi M. Ashique P. Manoj C. Hartmann A. Nemmar N. Schupp & B. H. Ali (2019). "The renoprotective effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on adenine-induced kidney disease in rats." Biomed Pharmacotherapy 110: 667-676.
- Kumar P., Sulakhiya K., Barua C. C., & Mundhe N. (2017). TNF-α, IL-6 and IL-10 expressions, responsible for disparity in action of curcumin against cisplatin-induced nephrotoxicity in rats. Molecular and Cellular Biochemistry, 431(1), 113-122.
- Zhu X., Jiang X., Li, A., Zhao Z., & Li S. (2017). S‐Allylmercaptocysteine attenuates cisplatin‐induced nephrotoxicity through suppression of apoptosis, oxidative stress, and inflammation. Nutrients, 9(2), 166.
- Zhang B., G. Ramesh C. C. Norbury and W. B. Reeves (2007). "Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells." Kidney International 72(1): 37-44.
- Choi S. H., J. Leem and I.-K. Lee (2017). "Protective Effects of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, against Cisplatin-Induced Nephrotoxicity in Mice." Mediators of Inflammation: 2017,11-28.
- TanakaT., Y. HigashijimaT. Wada &M. Nangaku (2014). "The potential for renoprotection with incretin-based drugs." Kidney International 86(4): 701-711.
- Sun A. L., Deng J. T., Guan G. J., Chen S. H., Liu Y. T., Cheng J., & Deng H. P. (2012). Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease. Diabetes and Vascular Disease Research, 9(4), 301-308.
- Hocher B., Reichetzeder C., & Alter M. L. (2012). Renal and cardiac effects of DPP4 inhibitors–from preclinical development to clinical research. Kidney and blood pressure research, 36(1), 65-84.
- RöhrbornD., Wronkowitz N., & Eckel J. (2015). DPP4 in diabetes. Frontiers In Immunology, 6, 386.
- Van Acker T., Buckle T., Van Malderen S. J., van Willigen D. M., van Unen V., van Leeuwen F. W., & Vanhaecke F. (2019). High-resolution imaging and single-cell analysis via laser ablation-inductively coupled plasma-mass spectrometry for the determination of membranous receptor expression levels in breast cancer cell lines using receptor-specific hybrid tracers. Analytica Chimica Acta, 1074, 43-53.
- El Amir Y. O., Omar W., Khabrani A. Y., Jahfali A. E., Alhakami S. M., & Dobab N. M. (2019). Protective effect of avenanthramides against cisplatin induced nephrotoxicity in rats. Journal of Advanced Veterinary and Animal Research, 6(4), 521.
- Abdel-Razek E. A. N., Abo-Youssef A. M., & Azouz A. A. (2020). Benzbromarone mitigates cisplatin nephrotoxicity involving enhanced peroxisome proliferator-activated receptor-alpha (PPAR-α) expression. Life Sciences, 243, 117272.
- Ali B. H., Al Salam S., Al Suleimani Y., Al Za'Abi M., Ashique M., Manoj P., ... & Nemmar A. (2020). Ameliorative Effect of Sesamin in Cisplatin-Induced Nephrotoxicity in Rats by Suppressing Inflammation, Oxidative/Nitrosative Stress, and Cellular Damage. Physiological Research, 69(1), 61-72.
- Humanes B., Lazaro A., Camano S., Moreno-Gordaliza E., Lazaro J. A., Blanco-Codesido M., & Tejedor A. (2012). Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats. Kidney international, 82(6), 652-663.
- Al Suleimani Y. M., A. M. Abdelrahman T. Karaca P. Manoj M. Ashique A. Nemmar and B. H. Ali (2018). "The effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on gentamicin nephrotoxicity in mice." Biomedical Pharmacothearpy 97: 1102-1108.
- Sakai M., Uchii M., Myojo K., Kitayama T., & Kunori S. (2015). Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats. European Journal of Pharmacology, 761, 109-115.
- Uchii M., Kimoto N., Sakai M., Kitayama, T., & Kunori S. (2016). Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats. European Journal of Pharmacology, 783, 56-63.
- Shalaby R.H., Rashed L.A., Ismaail A.E., Madkour N.K. and Elwakeel S.H. (2014): Hematopoietic stem cells derived from human umbilical cord ameliorate cisplatin-induced acute renal failure in rats. Am. J. Stem Cells, 3(2): 83–96.
- Prabhu V. V., Kannan N., & Guruvayoorappan, C. (2013). 1, 2-Diazole prevents cisplatin-induced nephrotoxicity in experimental rats. Pharmacological Reports, 65(4), 980-990.
|